PharmiWeb13h
Epsom Salt Council Sponsors the Arthritis Foundation's North Carolina Jingle Bell Runs to Benefit Critical Research Initiatives
CHARLOTTE, NC / ACCESSWIRE / November 18, 2024 / Epsom Salt Council, an organization dedicated to raising awareness about the health and wellness benefits of Epsom salt (magnesium sulfate), announces ...
PharmiWeb15m
Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event
MELBOURNE, AUSTRALIA / ACCESSWIRE / November 18, 2024 / Immuron Limited (NASDAQ:IMRN) has one commercial product and two pipeline assets in three clinical programs for the treatment of gut mediated ...
PharmiWeb47m
Bausch Health and Salix to Present at the American…
LAVAL, QC / ACCESSWIRE / November 18, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the first look at ...
PharmiWeb13h
Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets
CHICAGO, IL / ACCESSWIRE / November 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative ...
PharmiWeb13h
Why Is Mannitol Important in Vaccine Formulation?
Mannitol, chemical formula C6H14O6, is a white, crystalline powder with a sweet taste. It is classified as a sugar alcohol, which means it has characteristics of both sugars and alcohols. Mannitol is ...
PharmiWeb1h
When is It Necessary to Develop an Oral Liquid Formulation?
In the ever-evolving world of pharmaceutical development, the quest to innovate and improve the delivery of drug substances remains a top priority. Among the many formulation strategies, oral liquid ...
PharmiWeb13h
Cure51 launches NHS-approved study with Cambridge…
Pioneering Rosalind study aims to transform cancer treatment with insights from ‘super-responder’ patients Tumor samples from over 1,000 cancer survivors across three aggressive types will be analyzed ...
PharmiWeb13h
Protheragen-ING AI-Pharma’s AI-Powered Drug Discovery and Design Platform—A Paradigm Shift in Drug Development
In the ever-evolving landscape of pharmaceutical research and development, the demand for innovative and efficient drug discovery methods is more pressing than ever. At the forefront of this demanding ...
PharmiWeb3h
The King’s Fund calls on NHS leaders to help unlock power of industry partnerships
ABPI has today (Monday) welcomed a new report from The King’s Fund which explores the positive impacts of NHS and industry partnerships.
PharmiWeb3h
Quell Therapeutics Achieves Milestone for Type 1 Diabetes CAR-Treg Cell Therapy Program
Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announces that AstraZeneca has ...
PharmiWeb3h
BrightHeart Secures FDA Clearance for First AI Software Revolutionizing Prenatal Fetal Heart Ultrasound Evaluations
BrightHeart, a leading AI innovator in obstetric and pediatric cardiology technology, announces it has received FDA 510(k) clearance for its first artificial intelligence software, designed to ...
PharmiWeb3h
ICR Healthcare and Sponsors Host 12th Annual Healthcare Conference: Development, Deals and Dollars
ICR Healthcare, a leading global strategic communication, investor relations and capital markets advisory firm specializing in the healthcare sector, today hosts its 12th Annual Healthcare Conference: ...